详情页 - 河北大学附属医院知识库

资源类型：

文章类型：

作者：

Li, Jian[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] * ; Xu, Ye[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Zang, Aimin[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16]

; Gao, Yunong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Gao, Quanli[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Zhang, Yanqiao[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Wang, Dong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Xu, Jianming[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Yuan, Ying[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Jiang, Haiping[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Ying, Jieer[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Shi, Chunmei[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Deng, Yanhong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Wang, Jing[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Liu, Tianshu[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Huang, Yi[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Li, Zhezhen[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Wang, Huanli[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Liu, Shou[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Shen, Lin[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ;

机构： [1]Beijing Canc Hosp, Beijing, Peoples R China [2]Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China [3]Hebei Univ, Affiliated Hosp, Baoding, Hebei, Peoples R China [4]Henan Canc Hosp, Zhengzhou, Henan, Peoples R China [5]Harbin Med Univ, Canc Hosp, Dept Gastrointestinal Med Oncol, Harbin, Peoples R China [6]Chongqing Univ, Canc Hosp, Chongqing, Peoples R China [7]Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Beijing, Peoples R China [8]Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China [9]Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China [10]Univ Chinese Acad Sci, Canc Hosp, Beijing, Peoples R China [11]Fujian Med Univ, Union Hopsital, Fuzhou, Fujian, Peoples R China [12]Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Peoples R China [13]Hunan Canc Hosp, Changsha, Hunan, Peoples R China [14]Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China [15]Hubei Canc Hosp, Wuhan, Hubei, Peoples R China [16]BeiGene Shanghai Co Ltd, Shanghai, Peoples R China

出处：

DOI：

ISSN：

基金：

语种：

被引次数：

WOS：

中科院(CAS)分区：

出版当年[2022]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2021]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Beijing Canc Hosp, Beijing, Peoples R China [2]Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China [3]Hebei Univ, Affiliated Hosp, Baoding, Hebei, Peoples R China [4]Henan Canc Hosp, Zhengzhou, Henan, Peoples R China [5]Harbin Med Univ, Canc Hosp, Dept Gastrointestinal Med Oncol, Harbin, Peoples R China [6]Chongqing Univ, Canc Hosp, Chongqing, Peoples R China [7]Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Beijing, Peoples R China [8]Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China [9]Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China [10]Univ Chinese Acad Sci, Canc Hosp, Beijing, Peoples R China [11]Fujian Med Univ, Union Hopsital, Fuzhou, Fujian, Peoples R China [12]Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Peoples R China [13]Hunan Canc Hosp, Changsha, Hunan, Peoples R China [14]Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China [15]Hubei Canc Hosp, Wuhan, Hubei, Peoples R China [16]BeiGene Shanghai Co Ltd, Shanghai, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

A phase 2 study of tislelizumab monotherapy in patients with previously treated, locally advanced unresectable ormetastatic microsatellite instability-high/mismatch repair deficient solid tumors.

文献详情